QNRX Competitors & Alternatives
Compare Quoin Pharmaceuticals Ltd DRC with similar stocks in the same industry
Biotechnology
QNRX
Main Stock$3.28
-2.35%
Tradestie Score
44
Market Cap
$4.25M
P/E Ratio
7.6
Analyst Upside
+521.2%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Drug Discovery Biotech
Drug Design
Major Customers
3
specialty pharmacies
dermatology clinics
rare disease patients
Critical Suppliers
2
contract manufacturing organizations
CROs
Direct Ecosystem Rivals
0
Sole-source / monopoly positioning in sub-sector.
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.19
-0.97%
|
$133.50M | - | 42 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$28.46
-7.21%
|
$117.07M | - | 34 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.37
-4.30%
|
$110.20M | - | 44 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.31
+0.76%
|
$84.52M | - | 40 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$6.96
-1.14%
|
$67.94M | - | 48 | Compare |
|
ILAG
Intelligent Living Application Group Inc. Ordinary Shares
|
$1.53
-16.85%
|
$13.23M | - | 47 | Compare |
|
KPRX
Kiora Pharmaceuticals, Inc. Common Stock
|
$0.72
-12.28%
|
$9.72M | - | 47 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.36
-0.17%
|
$7.21M | - | 52 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$3.50
-5.15%
|
$3.42M | - | 47 | Compare |
|
VRAX
Virax Biolabs Group Limited Ordinary Shares
|
$0.33
-12.89%
|
$2.69M | - | 46 | Compare |
More QNRX Analysis
Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry